Speakers
Dave Tudor
Panel
"Dave brings over two decades of international experience in pharmaceutical manufacturing and supply chain strategy. During his 20+ year tenure at GSK, he held several senior leadership positions, including Vice President of Primary Supply chain and Vice President of Manufacturing Strategy.
Following his time at GSK, Dave served as Managing Director of the Medicines Manufacturing Innovation Centre at CPI, where he led initiatives to accelerate innovation and collaboration across the industry.
He now serves as Chief Executive Officer of Digital Technologies Group (DTG), where he continues to advance innovation in pharmaceutical manufacturing through digital transformation and strategic leadership."
Emilie Louvet is Director of Digital for Regulatory Affairs at AstraZeneca. She has been with AstraZeneca for 9 years holding a variety of roles with focus in generating insights from data; digital transformation and implementing AI solutions for drug development, clinical trial design and now regulatory.
Emilie has a MSc and PhD in Molecular and Cell Biology from Paris 5 University and Institut Jacques Monod (France), and an MBA in Business Management from the PowerMBA. Prior to moving to the industry, Emilie led her research at the Karolinska Institute (Sweden) and at Kyoto University (Japan). She then came back to Europe as head of digital pathology group at Gustave Roussy (France).